Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-008858

Chief Commercial Officer sold 11,890 shares at $1.87 ($22,230)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Piccina Cintia Chief Commercial Officer 2023-01-31 Sale −11,890 $1.87 $22,230 19,535 D
Open-market sales · 11,890 sh · avg $1.87 · $22,230
Loading xslF345X03/tm231655-21_4seq1.xml…